. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. Mol Neurodegener. 2016 Jan 12;11:3. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
sTREM2
(CSF)
AD
(24)
248.8 ± 102.6
ng/L §
SRM;
In-house;
In-house
sTREM2
(CSF)
AD
(37)
241 ± 93.7
ng/L §
SRM;
In-house;
In-house
sTREM2
(CSF)
CTRL-
CNC
(16)
192.3 ± 59.3
ng/L §
SRM;
In-house;
In-house
sTREM2
(CSF)
CTRL-
Other Controls
(22)
192.9 ± 63.7
ng/L §
SRM;
In-house;
In-house

§ Data supplied to Alzforum by author

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. TREM2 Goes Up in Spinal Fluid in Early Alzheimer’s

AlzBiomarker

  1. AD vs CTRL : sTREM2 (CSF)